These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 18846098)

  • 1. Do T cells need endogenous peptides for activation?
    Gascoigne NR
    Nat Rev Immunol; 2008 Nov; 8(11):895-900. PubMed ID: 18846098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Coreceptor function of CD4 in response to MHC class I molecule].
    Zvezdova ES; Grinenko TS; Pobezinskaia EL; Pobezinskiĭ LA; Kazanskiĭ DB
    Mol Biol (Mosk); 2008; 42(4):662-72. PubMed ID: 18856067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8 T cells, like CD4 T cells, are triggered by multivalent engagement of TCRs by MHC-peptide ligands but not by monovalent engagement.
    Stone JD; Stern LJ
    J Immunol; 2006 Feb; 176(3):1498-505. PubMed ID: 16424178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Division of labor by dendritic cells.
    Iwasaki A
    Cell; 2007 Feb; 128(3):435-6. PubMed ID: 17289563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.
    Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A
    J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
    Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
    Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors.
    Marzo AL; Lake RA; Robinson BW; Scott B
    Cancer Res; 1999 Mar; 59(5):1071-9. PubMed ID: 10070965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells.
    Adams EW; Ratner DM; Seeberger PH; Hacohen N
    Chembiochem; 2008 Jan; 9(2):294-303. PubMed ID: 18186095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparan sulfates targeting increases MHC class I- and MHC class II-restricted antigen presentation and CD8(+) T-cell response.
    Knittel D; Gadzinski A; Hua S; Denizeau J; Savatier A; de la Rochère P; Boulain JC; Amigorena S; Piaggio E; Sedlik C; Léonetti M
    Vaccine; 2016 Jun; 34(27):3093-3101. PubMed ID: 27154391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma cell necrosis facilitates transfer of specific sets of antigens onto MHC class II molecules of dendritic cells.
    Röhn TA; Schadendorf D; Sun Y; Nguyen XD; Roeder D; Langen H; Vogt AB; Kropshofer H
    Eur J Immunol; 2005 Oct; 35(10):2826-39. PubMed ID: 16163671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide-specific intercellular transfer of MHC class II to CD4+ T cells directly from the immunological synapse upon cellular dissociation.
    Wetzel SA; McKeithan TW; Parker DC
    J Immunol; 2005 Jan; 174(1):80-9. PubMed ID: 15611230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of CD8 and TCR binding to Class I MHC ligands following T cell activation.
    Kao C; Daniels MA; Jameson SC
    Int Immunol; 2005 Dec; 17(12):1607-17. PubMed ID: 16263755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell responses to bluetongue virus are directed against multiple and identical CD4+ and CD8+ T cell epitopes from the VP7 core protein in mouse and sheep.
    Rojas JM; Rodríguez-Calvo T; Peña L; Sevilla N
    Vaccine; 2011 Sep; 29(40):6848-57. PubMed ID: 21807057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Force-Regulated In Situ TCR-Peptide-Bound MHC Class II Kinetics Determine Functions of CD4+ T Cells.
    Hong J; Persaud SP; Horvath S; Allen PM; Evavold BD; Zhu C
    J Immunol; 2015 Oct; 195(8):3557-64. PubMed ID: 26336148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathways of antigen processing and presentation.
    Watts C; Powis S
    Rev Immunogenet; 1999; 1(1):60-74. PubMed ID: 11256573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response.
    Zhou G; Ding ZC; Fu J; Levitsky HI
    J Immunol; 2011 Feb; 186(4):2148-55. PubMed ID: 21242518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement for diverse, low-abundance peptides in positive selection of T cells.
    Barton GM; Rudensky AY
    Science; 1999 Jan; 283(5398):67-70. PubMed ID: 9872742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peripheral pool of CD8+ T-cells contains lymphocytes with antigen-specific receptors that recognize syngeneic MHC class II molecules].
    Pobezinskiĭ LA; Pobezinskaia EL; Grinenko TS; Chervonskiĭ AV; Kazanskiĭ DB
    Ontogenez; 2004; 35(3):183-9. PubMed ID: 15334820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small molecule modulators of MHC class II antigen presentation: mechanistic insights and implications for therapeutic application.
    Call MJ
    Mol Immunol; 2011 Sep; 48(15-16):1735-43. PubMed ID: 21676462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CD8 isoform CD8alphaalpha is not a functional homologue of the TCR co-receptor CD8alphabeta.
    Gangadharan D; Cheroutre H
    Curr Opin Immunol; 2004 Jun; 16(3):264-70. PubMed ID: 15134773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.